Clarivate Plc

• •Intelligence solutions with curated data and AI-enabled analytics
• •Workflow software for research, IP, and life sciences tasks
• •Tech-enabled expert services and consulting
• •Patent and trademark renewal services
• •Academic AI research assistants and agents
• •Cortellis regulatory, commercial, and medtech intelligence

Clarivate’s current strategy is to deepen its position in higher-value recurring revenue by shifting away from transactional sales and completing product wind-downs in selected lines. Management is also emphasizing AI adoption across the portfolio, including research assistants and agentic workflows, to improve customer productivity and defend the value of curated content against free or low-cost alternatives. The company is simplifying its business mix through divestitures and wind-downs, which should improve focus on core segments and reduce exposure to lower-quality revenue. It is also balancing product investment with debt service and liquidity management, reflecting the capital intensity of content, software, and acquisition-led growth.

Clarivate’s main risks stem from dependence on third-party data and public sources, because much of its value proposition is built on licensed content and integrated information feeds. The company also faces intense competition from established information providers, niche software vendors, search tools, and increasingly free or AI-generated alternatives, which can pressure pricing and demand. Its customer base includes academic, government, and life sciences buyers that often operate under constrained budgets, so spending cuts or slower research activity can reduce renewals and transactional demand. Cybersecurity, technology obsolescence, and the need to keep pace with AI and regulatory change are additional risks because service interruptions or product failures would directly damage trust in curated intelligence products.